Research Article
miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus
Table 1
Clinicopathological and laboratory data of SLE and control cases.
| | Parameters | SLE () | Healthy controls () |
| | Age (years) | | | | Gender (male/female), | 4/28 | 4/28 | | Arthritis, (%) | 19 (59.4%) | — | | Lupus nephritis, (%) | 15 (46.9%) | — | | Serositis, (%) | 10 (31.3%) | — | | Rash, (%) | 17 (53.1%) | — | | ANA, (%) | 32 (100%) | — | | ESR (mm/h) | | — | | CRP (mg/L) | | — | | Complement 3 (g/L) | | — | | Anti-dsDNA antibody (IU/mL) | | — | | SLEDAI score | | — |
|
|
The average data of age, ESR, CRP, complement 3, anti-dsDNA, and SLEDAI score are presented as the . |
